Menu Back to DIA-Annual-Canadian-Meeting

Overview

The DIA Annual Canadian Meeting will deliver a comprehensive overview of the current bio-pharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships to key regulatory and clinical considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Bringing together key stakeholders from the drug/device and Patient Self Care industries, regulatory agencies, and academia, this meeting will discuss and analyze the relevant challenges and opportunities for professionals working in the field in Canada.

Testimonials

The DIA is an opportunity for veterans and freshmen alike to learn and better understand the landscape of the current regulatory world, and participate in building a future where patients, physicians, regulators, payer and the industry can live healthier. -2019 Attendee

A fantastic venue for exchange of new information, clarification on evolving regulations and future directions. -2019 Attendee


Call for Abstracts

The Program Committee is inviting abstract submissions for both Professionals and Resident and Fellows. The deadline to submit is December 20.

View Professional Guidelines

Submit here.


Program Committee

  • Marc F. Poitras, PhD, MBA
    Marc F. Poitras, PhD, MBA Scientific Manager, Marketed Pharmaceuticals and Medical Devices Bureau
    Health Canada, Canada
  • Lisa  Chartrand
    Lisa Chartrand Director, Regulatory Strategy and Policy
    Hoffmann-La Roche Limited, Canada
  • Samar  Darwish, MSc
    Samar Darwish, MSc Director,Drug Regulatory Affairs
    Boehringer Ingelheim Canada, Canada
  • Judith  Mergl, MSc
    Judith Mergl, MSc Director, Regulatory Affairs & Operations
    Abbvie Corporation, Canada
  • Melissa  Hunt, MSc
    Melissa Hunt, MSc Director
    Health Canada, Canada
  • Yatika  Kohli, PhD, MBA
    Yatika Kohli, PhD, MBA Executive Director - Global Regulatory Affairs
    NoNO Inc, Canada
  • Lorella  Garofalo, PhD
    Lorella Garofalo, PhD Director, Regulatory Affairs Canada; Global Regulatory Affairs International
    Pfizer Canada ULC, Canada
  • Kristin  Willemsen, MS
    Kristin Willemsen, MS Director of Scientific & Regulatory Affairs
    Consumer Health Products Canada, Canada
  • Fiona M Frappier, PhD
    Fiona M Frappier, PhD Senior Policy Analyst
    Health Canada, Canada
  • Rania  Mouchantaf, PhD
    Rania Mouchantaf, PhD Associate Director
    Health Canada, Canada
Load More

Contact us

Registration Questions?

Send Email
1.888.257.6457


Digital Learning Catalog

DIA Learning: eLearning Soultions
Download